Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes

Nature Genetics

Volumn 39, Issue 9, 2007, Pages 1074-1082

  Lowe, Christopher E ^a   Cooper, Jason D ^a   Brusko, Todd ^b   Walker, Neil M ^a   Smyth, Deborah J ^a   Bailey, Rebecca ^a   Bourget, Kirsi ^a   Plagnol, Vincent ^a   Field, Sarah ^a   Atkinson, Mark ^b   Clayton, David G ^a   Wicker, Linda S ^a   Todd, John A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 2 RECEPTOR ALPHA; RNA BINDING PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE MAPPING; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; INTRON; PRIORITY JOURNAL; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

CHROMOSOME MAPPING; DIABETES MELLITUS, TYPE 1; FAMILY HEALTH; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 34548367511     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng2102     Document Type: Article

References (49)

1. Wang, W.Y., Barratt, B.J., Clayton, D.G. & Todd, J.A. Genome-wide association studies: theoretical and practical concerns. Nat. Rev. Genet. 6, 109-118 (2005).
2. Dewan, A. et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 314, 989-992 (2006).
3. Duerr, R.H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461-1463 (2006).
4. Todd, J.A. Statistical false positive or true disease pathway? Nat. Genet. 38, 731-733 (2006).
5. Todd, J.A. et al. Robust associations of four new chromosome regions from genomewide analyses of type 1 diabetes. Nat. Genet. 39, 857-864 (2007).
6. Frayling, T.M. et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316, 889-894 (2007).
7. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678 (2007).
8. Ueda, H. et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423, 506-511 (2003).
9. Vella, A. et al. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am. J. Hum. Genet. 76, 773-779 (2005).
10. Qu, H.Q., Montpetit, A., Ge, B., Hudson, T.J. & Polychronakos, C. Toward further mapping of the association between the IL2RA locus and type 1 diabetes. Diabetes 56, 1174-1176 (2007).
11. Brand, O.J. et al. Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs. Clin. Endocrinol. 66, 508-512 (2007).
12. Fehniger, T.A. & Caligiuri, M.A. Interleukin 15: biology and relevance to human disease. Blood 97, 14-32 (2001).
13. Waldmann, T.A. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat. Rev. Immunol. 6, 595-601 (2006).
14. Kuniyasu, Y. et al. Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int. Immunol. 12, 1145-1155 (2000).
15. Yamanouchi, J. et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat. Genet. 39, 329-337 (2007).
16. Robb, R.J. & Kutny, R.M. Structure-function relationships for the IL 2-receptor system. IV. Analysis of the sequence and ligand-binding properties of soluble Tac protein. J. Immunol. 139, 855-862 (1987).
17. Bleesing, J. et al. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated newonset systemic juvenile idiopathic arthritis. Arthritis Rheum. 56, 965-971 (2007).
18. Makis, A.C. et al. Serum levels of soluble interleukin-2 receptor alpha (sIL-2Ralpha) as a predictor of outcome in brucellosis. J. Infect. 51, 206-210 (2005).
19. Kim, H.P., Imbert, J. & Leonard, W.J. Both integrated and differential regulation of components of the IL-2/IL-2 receptor system. Cytokine Growth Factor Rev. 17, 349-366 (2006).
20. The International HapMap Consortium. The International HapMap Project. Nature 426, 789-796 (2003).
21. The International HapMap Consortium. A haplotype map of the human genome. Nature 437, 1299-1320 (2005).
22. Clayton, D.G. et al. Population structure, differential bias and genomic control in a large-scale, case-control association study. Nat. Genet. 37, 1243-1246 (2005).
23. Hardenbol, P. et al. Multiplexed genotyping with sequence-tagged molecular inversion probes. Nat. Biotechnol. 21, 673-678 (2003).
24. Spielman, R.S., McGinnis, R.E. & Ewens, W.J. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52, 506-516 (1993).
25. Klose, R.J. & Bird, A.P. Genomic DNA methylation: the mark and its mediators. Trends Biochem. Sci. 31, 89-97 (2006).
26. Roh, T.Y., Cuddapah, S., Cui, K. & Zhao, K. The genomic landscape of histone modifications in human T cells. Proc. Natl. Acad. Sci. USA 103, 15782-15787 (2006).
27. Bell, G.I., Horita, S. & Karam, J.H. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 33, 176-183 (1984).
28. Naranjo-Gomez, M. et al. Expression and function of the IL-2 receptor in activated human plasmacytoid dendritic cells. Eur. J. Immunol 37, 1764-1772 (2007).
29. Giordano, C. et al. Interleukin 2 and soluble interleukin 2-receptor secretion defect in vitro in newly diagnosed type I diabetic patients. Diabetes 38, 310-315 (1989).
30. Leonard, W.J. et al. Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature 311, 626-631 (1984).
31. Tree, T.I., Roep, B.O. & Peakman, M. A mini meta-analysis of studies on CD4+CD25+ T cells in human type 1 diabetes: report of the Immunology of Diabetes Society T Cell Workshop. Ann. NY Acad. Sci. 1079, 9-18 (2006).
32. Rubinstein, M.P. et al. Converting IL-15 to a superagonist by binding to soluble IL-15RA. Proc. Natl. Acad. Sci. USA 103, 9166-9171 (2006).
33. Power, C. & Elliott, J. Cohort profile: 1958 British birth cohort (National Child Development Study). Int. J. Epidemiol. 35, 34-41 (2006).
34. Bain, S.C., Todd, J.A. & Barnett, A.H. The British Diabetic Association-Warren repository. Autoimmunity 7, 83-85 (1990).
35. Feltbower, R.G., McKinney, P.A., Parslow, R.C., Stephenson, C.R. & Bodansky, H.J. Type 1 diabetes in Yorkshire, UK: time trends in 0-14 and 15-29-year-olds, age at onset and age-period-cohort modelling. Diabet. Med. 20, 437-441 (2003).
36. Lernmark, A. et al. Family cell lines available for research. Am. J. Hum. Genet. 47, 1028-1030 (1990).
37. Patterson, C.C., Carson, D.J. & Hadden, D.R. Epidemiology of childhood IDDM in Northern Ireland 1989-1994: low incidence in areas with highest population density and most household crowding. Northern Ireland Diabetes Study Group. Diabetologia 39, 1063-1069 (1996).
38. Smyth, D.J. et al. Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes. Nat. Genet. 37, 110-111 (2005).
39. Undlien, D.E. et al. No difference in the parental origin of susceptibility HLA class II haplotypes among Norwegian patients with insulin-dependent diabetes mellitus. Am. J. Hum. Genet. 57, 1511-1514 (1995).
40. Ionescu-Tirgoviste, C. et al. Low frequency of HLA DRB1*03 - DQB1*02 and DQB1*0302 haplotypes in Romania is consistent with the country's low incidence of Type I diabetes. Diabetologia 44 (Suppl. 3), B60-B66 (2001).
41. Smink, L.J. et al. T1DBase, a community web-based resource for type 1 diabetes research. Nucleic Acids Res. 33, D544-D549 (2005).
42. Bonfield, J.K., Rada, C. & Staden, R. Automated detection of point mutations using fluorescent sequence trace subtraction. Nucleic Acids Res. 26, 3404-3409 (1998).
43. She, J.X. et al. Heterophile antibodies segregate in families and are associated with protection from type 1 diabetes. Proc. Natl. Acad. Sci. USA 96, 8116-8119 (1999).
44. Plagnol, V., Cooper, J.D., Todd, J.A. & Clayton, D.G. A method to address differential bias in genotyping in large-scale association studies. PLoS Genet. [online] 3, e74 (2007)(doi:10.1371/journal.pgen. 0030074).
45. Chapman, J.M., Cooper, J.D., Todd, J.A. & Clayton, D.G. Detecting disease associations due to linkage disequilibrium using haplotype tags: a class of tests and the determinants of statistical power. Hum. Hered. 56, 18-31 (2003).
46. Scheet, P. & Stephens, M. A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. Am. J. Hum. Genet. 78, 629-644 (2006).
47. Barrett, J.C., Fry, B., Maller, J. & Daly, M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265 (2005).
48. Burren, O.S. et al. Development of an integrated genome informatics, data management and workflow infrastructure: a toolbox for the study of complex disease genetics. Hum. Genomics 1, 98-109 (2004).
49. Cordell, H.J. & Clayton, D.G. A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am. J. Hum. Genet. 70, 124-141 (2002).